Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
E3DEYjJ6BnqNwvBF